Table of Contents
Healthcare Company Valuation Methods: From Comparable Company Analysis to rNPV
Why is it that among innovative drug companies, some can achieve high valuations while others struggle to gain capital recognition?
Healthcare company valuation differs significantly from that of traditional industries.
I. Revenue is Not the Only Valuation Metric
For mature companies, revenue, profit, and cash flow are usually the important bases for valuation.
However, for early-stage healthcare companies:
- They are not yet commercialized;
- They have not yet generated revenue;
- Their products are still in the clinical stage;
Traditional valuation methods often fail to fully reflect the company’s value.
II. rNPV is Commonly Used for Innovative Drug Companies
For innovative drug companies, risk-adjusted net present value (rNPV) is an important valuation method.
It usually needs to consider:
- The probability of clinical success;
- Development costs;
- Time to market;
- Market size;
- Product price;
- Commercialization costs;
- Patent life cycle.
Therefore, drug valuation is essentially a comprehensive judgment of future cash flows and R&D risks.
III. Comparable Company Analysis
Comparable company analysis can be used to compare the target company horizontally through indicators such as:
- Market capitalization;
- Enterprise value;
- Revenue;
- EBITDA;
- Pipeline value.
However, the selection of comparable companies in the healthcare industry needs to be very cautious.
IV. Valuation of Medical Device Companies
Medical device companies usually need to consider a combination of factors:
- Product registration;
- Clinical data;
- Installed base;
- Revenue growth;
- Market share;
- Gross margin;
- Product pipeline;
- Overseas markets.
T-Capital’s View
There is no simple formula for healthcare company valuation.
A truly reasonable valuation requires a simultaneous understanding of:
Technology, clinical, commercial, capital, and industry.
This is also one of the important values of a professional financial advisor in healthcare transactions.